(Q35035514)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505316%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

review article

1 reference

title

Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505316%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505316%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Simon M Pyke

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505316%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Philip C Burcham

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505316%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Frank R Fontaine

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505316%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Dennis R Petersen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505316%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

language of work or name

English

0 references

publication date

1 December 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505316%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

number of pages

8

1 reference

inferred from page(s)

published in

Toxicology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505316%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

181-182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505316%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

229-236

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505316%20AND%20SRC:MED&resulttype=core&format=json

Efficient scavenging of fatty acid oxidation products by aminoguanidine

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Hydralazine-induced vasodilation involves opening of high conductance Ca2+-activated K+ channels.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Biotransformation of the cardiovascular toxin, allylamine, by rat and human cardiovascular tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

In vivo metabolism of the cardiovascular toxin, allylamine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Diminished susceptibility to proteolysis after protein modification by the lipid peroxidation product malondialdehyde: inhibitory role for crosslinked and noncrosslinked adducted proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

The antihypertensive hydralazine is an efficient scavenger of acrolein.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Synthesis and characterization of the fluorescent products derived from malonaldehyde and amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Lipid peroxidation and biogenic aldehydes: from the identification of 4-hydroxynonenal to further achievements in biopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

The role of phenolics, conjugated linoleic acid, carnosine, and pyrroloquinoline quinone as nonessential dietary antioxidants.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Renoprotective effects of a novel inhibitor of advanced glycation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Protective effects of carnosine against malondialdehyde-induced toxicity towards cultured rat brain endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Protective effects of carnosine against protein modification mediated by malondialdehyde and hypochlorite

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Endogenous mechanisms of neuroprotection: role of zinc, copper, and carnosine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

The reaction of some dicarbonyl sugars with aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

The reaction of D-glucose with aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Effect of aminoguanidine on lipid peroxidation in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Influence of hydralazine consumption on allylamine induced myocardial fibrosis and hypertrophy in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Hemoglobin-AGE: a circulating marker of advanced glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Allylamine cardiotoxicity--IV. Metabolism to acrolein by cardiovascular tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Hydralazine and related compounds: chemistry, metabolism, and mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Synthesis, formulation, and clinical pharmacological evaluation of hydralazine pyruvic acid hydrazone in two healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Chronic aminoguanidine attenuates renal dysfunction and injury in aging rats

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Conversion of allyl alcohol into acrolein by rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Carbonyl-trapping therapeutic strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Allyl alcohol- and acrolein-induced toxicity in isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Inhibition of cataracts in moderately diabetic rats by aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Role of reactive aldehyde in cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Identification of hydrazine in commercial preparations of carnosine and its influence on carnosine's antioxidative properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

Ability of carnosine and other skeletal muscle components to quench unsaturated aldehydic lipid oxidation products

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900287-1

7 January 2021

10.1016/S0300-483X(02)00287-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505316%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference